A Randomized Trial Comparing Defined-Duration With Continuous Irinotecan Until Disease Progression in Fluoropyrimidine and Thymidylate Synthase InhibitorResistant Advanced Colorectal Cancer.
Journal of Clinical Oncology
Vol 22, No 15 (August 1), 2004: pp. 3023-3031
Rohit Lal, James Dickson, David Cunningham, Ian Chau, Andrew R. Norman, Paul J. Ross, Clare Topham, Gary Middleton, Mark Hill, Jacqui Oates
DOI: 10.1200/JCO.2004.01.005
Go to journal article.

